# Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

> **NCT06971380** · PHASE2 · RECRUITING · sponsor: **Polina Stepensky** · enrollment: 180 (estimated)

## Conditions studied

- Multiple Myeloma, Refractory to Standard Treatment
- Multiple Myeloma, Relapsed
- Light Chain Amyloidosis

## Interventions

- **BIOLOGICAL:** HBI0101 CART

## Key facts

- **NCT ID:** NCT06971380
- **Lead sponsor:** Polina Stepensky
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2028-05-15
- **Final completion:** 2030-05-15
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06971380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06971380, "Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06971380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*